Print Friendly, PDF & Email

NCT/Study#

NCT04220190 /

RAPA-501-ALS

Phase I Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) for Amyotrophic Lateral Sclerosis

DISEASE GROUP:

Transplant

current phase:

Phase I

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587